Impact of transcription factors KLF1 and GATA1 on red blood cell antigen expression: a review

GATA1公司 生物 表型 基因 转录因子 关贸总协定 遗传学 抗原 等位基因
作者
Genghis H. Lopez,Mia E. Sarri,Robert L. Flower,Catherine A. Hyland
出处
期刊:Immunohematology / American Red Cross [Exeley Inc]
卷期号:40 (1): 1-9
标识
DOI:10.2478/immunohematology-2024-002
摘要

Abstract KLF transcription factor 1 (KLF1) and GATA binding protein 1 (GATA1) are transcription factors (TFs) that initiate and regulate transcription of the genes involved in erythropoiesis. These TFs possess DNA-binding domains that recognize specific nucleotide sequences in genes, to which they bind and regulate transcription. Variants in the genes that encode either KLF1 or GATA1 can result in a range of hematologic phenotypes—from benign to severe forms of thrombocytopenia and anemia; they can also weaken the expression of blood group antigens. The Lutheran (LU) blood group system is susceptible to TF gene variations, particularly KLF1 variants. Individuals heterozygous for KLF1 gene variants show reduced Lutheran antigens on red blood cells that are not usually detected by routine hemagglutination methods. This reduced antigen expression is referred to as the In(Lu) phenotype. For accurate blood typing, it is important to distinguish between the In(Lu) phenotype, which has very weak antigen expression, and the true Lu null phenotype, which has no antigen expression. The International Society of Blood Transfusion blood group allele database registers KLF1 and GATA1 variants associated with modified Lutheran expression. Here, we review KLF1 and recent novel gene variants defined through investigating blood group phenotype and genotype discrepancies or, for one report, investigating cases with unexplained chronic anemia. In addition, we include a review of the GATA1 TF, including a case report describing the second GATA1 variant associated with a serologic Lu(a–b–) phenotype. Finally, we review both past and recent reports on variations in the DNA sequence motifs on the blood group genes that disrupt the binding of the GATA1 TF and either remove or reduce erythroid antigen expression. This review highlights the diversity and complexity of the transcription process itself and the need to consider these factors as an added component for accurate blood group phenotyping.

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
开朗艳一完成签到,获得积分10
1秒前
Vvvnnnaa1发布了新的文献求助10
3秒前
CarterXD完成签到,获得积分10
3秒前
NEWEST发布了新的文献求助10
3秒前
5秒前
CipherSage应助divine_2025采纳,获得10
5秒前
虫虫们发布了新的文献求助20
6秒前
6秒前
6秒前
小蘑菇应助科研通管家采纳,获得10
6秒前
科研通AI6应助科研通管家采纳,获得10
6秒前
思源应助科研通管家采纳,获得10
6秒前
小蘑菇应助科研通管家采纳,获得10
6秒前
zhonglv7应助科研通管家采纳,获得10
7秒前
wanci应助科研通管家采纳,获得10
7秒前
wanci应助科研通管家采纳,获得10
7秒前
我是老大应助科研通管家采纳,获得10
7秒前
海洋完成签到,获得积分10
7秒前
科研通AI6应助科研通管家采纳,获得10
7秒前
星辰大海应助科研通管家采纳,获得10
7秒前
田様应助科研通管家采纳,获得10
7秒前
完美世界应助科研通管家采纳,获得10
7秒前
欢喜的非笑完成签到 ,获得积分10
7秒前
科研通AI6应助科研通管家采纳,获得10
7秒前
科研通AI2S应助科研通管家采纳,获得30
7秒前
Hello应助科研通管家采纳,获得10
7秒前
科研通AI6应助科研通管家采纳,获得10
7秒前
今后应助科研通管家采纳,获得10
7秒前
fei菲飞发布了新的文献求助10
7秒前
科研通AI6应助科研通管家采纳,获得10
7秒前
无语的凡梦完成签到,获得积分10
7秒前
研友_VZG7GZ应助科研通管家采纳,获得200
7秒前
田様应助科研通管家采纳,获得10
7秒前
科研通AI6应助科研通管家采纳,获得10
8秒前
科研通AI6应助科研通管家采纳,获得10
8秒前
科研通AI6应助科研通管家采纳,获得10
8秒前
8秒前
8秒前
科研通AI6应助科研通管家采纳,获得10
8秒前
专注凌文发布了新的文献求助10
9秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Vertébrés continentaux du Crétacé supérieur de Provence (Sud-Est de la France) 600
A complete Carnosaur Skeleton From Zigong, Sichuan- Yangchuanosaurus Hepingensis 四川自贡一完整肉食龙化石-和平永川龙 600
FUNDAMENTAL STUDY OF ADAPTIVE CONTROL SYSTEMS 500
微纳米加工技术及其应用 500
Nanoelectronics and Information Technology: Advanced Electronic Materials and Novel Devices 500
Performance optimization of advanced vapor compression systems working with low-GWP refrigerants using numerical and experimental methods 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 纳米技术 计算机科学 内科学 化学工程 复合材料 物理化学 基因 遗传学 催化作用 冶金 量子力学 光电子学
热门帖子
关注 科研通微信公众号,转发送积分 5304842
求助须知:如何正确求助?哪些是违规求助? 4451080
关于积分的说明 13850819
捐赠科研通 4338377
什么是DOI,文献DOI怎么找? 2381863
邀请新用户注册赠送积分活动 1376934
关于科研通互助平台的介绍 1344361